Endo News Roundup: Diabetic Retinopathy

New studies in diabetes highlight the use of real-time continuous glucose monitoring in type 1 diabetes mellitus (DM) to reduce hemoglobin A1c (HbA1c), primarily in those over age 15 years; how a teleretinal diabetic retinopathy screening program can reduce wait times for screening and improve timeliness of needed care; and note that many young diabetes patients who have health insurance do not receive timely eye examinations to monitor for diabetic retinopathy.